Icotrokinra Outperforms Deucravacitinib In Head-To-Head Trials
29 Sep 2025 //
PHARMAWEB
Protagonist Presents Icotrokinra Data for Plaque Psoriasis
17 Sep 2025 //
PHARMAWEB
Protagonist`s Icotrokinra Ph 2b Data to be Presented at UEG Week
15 Sep 2025 //
ACCESSWIRE
J&J Pursues 1st EMA Approval for Icotrokinra in Plaque Psoriasis
11 Sep 2025 //
GLOBENEWSWIRE
Protagonist Submits Icotrokinra EMA Application for Psoriasis
11 Sep 2025 //
ACCESSWIRE
Icotrokinra: 75% of adolescents with psoriasis achieve clear skin
10 Apr 2025 //
PR NEWSWIRE